Evangelisti C; Evangelisti C; Teti G; Falconi M; Cappellini A;
Chiarini F; Buontempo F; Bressanin D; Lonetti A; Spartà A;
Bittman R; Pyne S; Pyne N; Martelli AM, ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS,
UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC
LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS, in: Haematologica, «HAEMATOLOGICA», 2014, pp. 83 - 83 (atti di: XIII Congresso della Società Italiana di Ematologia Sperimentale, Rimini, 15-18 October 2014) [atti di convegno-poster]
Martelli A.M.; Buontempo F.; Evangelisti C., GSK-3β: a key regulator of breast cancer drug resistance, «CELL CYCLE», 2014, 13, pp. 697 - 698 [replica/breve intervento]
A Lonetti; A Cappellini; A Spartà; D Bressanin; F Buontempo; F Chiarini; C Evangelisti; E Orsini; A Martelli, INHIBITION OF CLASS I PHOSPHATIDYLINOSITOL 3-KINASES (PI3KS) ISOFORMS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): WHICH IS THE BEST THERAPEUTIC STRATEGY?, in: Vol 99, Issue supplement 1, «HAEMATOLOGICA», 2014, pp. 274 - 274 (atti di: 19th Congress of the European Hematology Association, Milano, June 12–15, 2014) [atti di convegno-abstract]
A.M. Martelli; A. Lonetti; F. Buontempo; F. Ricci; P.L. Tazzari; C. Evangelisti; D. Bressanin; A. Cappellini; E. Orsini; F. Chiarini., Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells., «ADVANCES IN BIOLOGICAL REGULATION», 2014, 56, pp. 6 - 21 [articolo]
Camilla Evangelisti; Cecilia Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontempo; Daniela Bressanin; Alessandra Cappellini; Ester Orsini; James A. McCubrey; Alberto Maria Martelli., Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia, «INTERNATIONAL JOURNAL OF ONCOLOGY», 2014, 45, pp. 909 - 918 [articolo]
A.M. Spartà; D. Bressanin; F. Chiarini; A. Lonetti; A. Cappellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A.M. Martelli., Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia., «CELL CYCLE», 2014, 13, pp. 2237 - 2247 [articolo]
W.H. Chappell; S.L. Abrams; K.M. Stadelman; M.M. LaHair; R.A. Franklin; L. Cocco; C. Evangelisti; F. Chiarini; A.M. Martelli; L.S. Steelman; J.A. McCubrey., Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment., «ADVANCES IN BIOLOGICAL REGULATION», 2013, 53, pp. 146 - 155 [articolo]
J.A. McCubrey; L.S. Steelman; W.H. Chappell; S.L. Abrams; R.A. Franklin; G. Montalto; M. Cervello; F. Nicoletti; G. Malaponte; C. Massarino; M. Libra; J. Bäsecke; A. Tafuri; M. Milella; F. Chiarini; C. Evangelisti; L. Cocco; A.M. Martelli., New agents and approaches for targeting the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR cell survival pathways., in: Cell Death Signaling in Cancer Biology and Treatment, NEW YORK CITY, Humana Press, 2013, pp. 331 - 372 [capitolo di libro]
C. Evangelisti; C. Evangelisti; D. Bressanin; F. Buontempo; F. Chiarini; A Lonetti; M Soncin; A.M. Spartà; J. A. McCubrey; A.M. Martelli., Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia., «EXPERT OPINION ON THERAPEUTIC TARGETS», 2013, 17, pp. 921 - 936 [articolo]
J.A. McCubrey; L.S. Steelman; W.H. Chappell; L. Sun; N.M. Davis; S.L. Abrams; R.A. Franklin; L. Cocco; C. Evangelisti; F. Chiarini; A.M. Martelli; M. Libra; S. Candido; G. Ligresti; G. Malaponte; M.C. Mazzarino; P. Fagone; M. Donia; F. Nicoletti; J. Polesel; R. Talamini; J. Bäsecke; S. Mijatovic; D. Maksimovic-Ivanic; M. Milella; A. Tafuri; J. Dulińska-Litewka; P. Laidler; A. B. D’Assoro; L. Drobot ; K. Umezawa; G. Montalto; M. Cervello; Z. N. Demidenko., Advances in Targeting Signal Transduction Pathways., «ONCOTARGET», 2012, 3, pp. 1505 - 1521 [articolo]
Simioni C; Neri LM; Tabellini G; Ricci F; Bressanin D; Chiarini F; Evangelisti C; Cani A; Tazzari PL; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Capitani S; Martelli AM., Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia., «LEUKEMIA», 2012, 26, pp. 2336 - 2342 [articolo]
M. Okada; Y. Hozumi; T. Tanaka; Y. Suzuki; M. Yanagida; Y. Araki; C. Evangelisti; H. Yagisawa; M.K. Topham; A.M. Martelli; K. Goto, DGKζ is degraded through the cytoplasmic ubiquitin-proteasome system under excitotoxic conditions, which causes neuronal apoptosis because of aberrant cell cycle reentry., «CELLULAR SIGNALLING», 2012, 24, pp. 1573 - 1582 [articolo]
D. Bressanin; C. Evangelisti; F. Ricci; G. Tabellini; F. Chiarini; P.L. Tazzari; F. Melchionda; F. Buontempo; P. Pagliaro; A. Pession; J.A. McCubrey; A.M. Martelli., Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels., «ONCOTARGET», 2012, 3, pp. 811 - 823 [articolo]
J.A. McCubrey; L.S. Steelman; W.H. Chappell; S.L. Abrams;G. Montalto; M. Cervello; F. Nicoletti; P. Fagone; Graziella Malaponte; M.C. Mazzarino; S. Candido; M. Libra; J. Bäsecke; S. Mijatovic; D. Maksimovic-Ivanic; M. Milella; A. Tafuri; L. Cocco; C. Evangelisti; F. Chiarini; A.M. Martelli., Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response., «ONCOTARGET», 2012, 3, pp. 954 - 987 [articolo]
Alberto M. Martelli;Giovanna Tabellini;Francesca Ricci;Camilla Evangelisti;Francesca Chiarini;Roberta Bortul;James A. McCubrey;Francesco Antonio Manzoli, PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy, in: Advances in Biological Regulation, 2012, 52, pp. 214 - 227 (atti di: FIFTY SECOND INTERNATIONAL SYMPOSIUM ON REGULATION OF ENZYME ACTIVITY AND SYNTHESIS IN NORMAL AND NEOPLASTIC TISSUES, Bologna, Italia, 26-27 settembre 2011) [Contributo in Atti di convegno]
